ÌÇÐÄvlog¹ÙÍø

CRISPR Democracy: Gene Editing and the Need for Inclusive Deliberation

Not since the early, heady days of recombinant DNA (rDNA) has a technique of molecular biology so gripped the scientific imagination as the CRISPR-Cas9 method of gene editing.

Healthcare Exceptionalism? Performance and Allocation in the U.S. Healthcare Sector

The conventional wisdom in health economics is that idiosyncratic features of the healthcare sector leave little scope for market forces to allocate consumers to higher performance producers.

Correcting Signals for Innovation in Health Care

A combination of legal rules and institutional forces pushes health plans to cover nearly every medical innovation.

The Use of Experiments in Health Care

Two of the best known randomized trials in health economics are described in detail in this chapter, the RAND Health Insurance Experiment and the Oregon Health Insurance Experiment.

A Comparison of Relative Resource Use and Quality in Medicare Advantage Health Plans Versus Traditional Medicare.

Prior analyses of Medicare health plans have examined either utilization of services or quality of care, but not both jointly.

Competition in the Age of Biosimilars

In March 2015, the US Food and Drug Administration (FDA) approved the first biosimilar in the United States, ushering in the age of biosimilar competition for biologics.

Emotions and Health Decision-Making: Extending the Appraisal Tendency Framework to Improve Health and Healthcare

Bioethical Prescriptions

In this article, the author responds to the articles within the issue that commented on his book "Bioethical Prescriptions." Topics discussed include the importance of certain types of temporal order

Comparative Effectiveness of Human Papillomavirus Vaccination Against Cervical Abnormalities by Dose Level in a Cohort of Privately-Insured U.S. Girls

Human papillomavirus (HPV) vaccines prevent infection with the most cancer-causing HPV types. However, many age-eligible girls do not initiate or complete the three-dose regimen.

Comparison of Self-Reported and Medicare Claims-Identified Acute Myocardial Infarction

Background–Cardiovascular disease is often studied through patient self-report and administrative data. However, these 2 sources provide different information, and few studies have compared them.